BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 23318480)

  • 21. Association Between Use of Thiopurines or Tumor Necrosis Factor Antagonists Alone or in Combination and Risk of Lymphoma in Patients With Inflammatory Bowel Disease.
    Lemaitre M; Kirchgesner J; Rudnichi A; Carrat F; Zureik M; Carbonnel F; Dray-Spira R
    JAMA; 2017 Nov; 318(17):1679-1686. PubMed ID: 29114832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thiopurine therapy in inflammatory bowel disease.
    Ha C; Dassopoulos T
    Expert Rev Gastroenterol Hepatol; 2010 Oct; 4(5):575-88. PubMed ID: 20932143
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factors associated with pregnancy outcome in anti-TNF treated women with inflammatory bowel disease.
    Seirafi M; de Vroey B; Amiot A; Seksik P; Roblin X; Allez M; Peyrin-Biroulet L; Marteau P; Cadiot G; Laharie D; Boureille A; De Vos M; Savoye G; Rahier JF; Carbonnel F; Bonaz B; Colombel JF; Bouhnik Y
    Aliment Pharmacol Ther; 2014 Aug; 40(4):363-73. PubMed ID: 24980270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of azathioprine on birth outcomes in women with inflammatory bowel disease (IBD).
    Shim L; Eslick GD; Simring AA; Murray H; Weltman MD
    J Crohns Colitis; 2011 Jun; 5(3):234-8. PubMed ID: 21575887
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective study of the effects of concomitant medications on thiopurine metabolism in inflammatory bowel disease.
    Daperno M; Sostegni R; Canaparo R; Serpe L; Lavagna A; Crocellà L; Castagno F; Vernetto A; Rigazio C; Ercole E; D'Antico S; Pera A; Zara G; Rocca R
    Aliment Pharmacol Ther; 2009 Oct; 30(8):843-53. PubMed ID: 19650826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thiopurines during pregnancy in inflammatory bowel disease: is there a risk for the (unborn) child?
    de Boer NK; de Meij T; van Bodegraven AA
    Expert Rev Gastroenterol Hepatol; 2013 Nov; 7(8):669-71. PubMed ID: 24134152
    [No Abstract]   [Full Text] [Related]  

  • 27. The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study.
    Francella A; Dyan A; Bodian C; Rubin P; Chapman M; Present DH
    Gastroenterology; 2003 Jan; 124(1):9-17. PubMed ID: 12512024
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The safety and efficacy of antitumour necrosis factor-alpha therapy for inflammatory bowel disease in patients post liver transplantation: a case series.
    Sandhu A; Alameel T; Dale CH; Levstik M; Chande N
    Aliment Pharmacol Ther; 2012 Jul; 36(2):159-65. PubMed ID: 22616981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outcome of a third anti-TNF monoclonal antibody after the failure of two prior anti-TNFs in inflammatory bowel disease.
    de Silva PS; Nguyen DD; Sauk J; Korzenik J; Yajnik V; Ananthakrishnan AN
    Aliment Pharmacol Ther; 2012 Sep; 36(5):459-66. PubMed ID: 22784296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medical management of the pregnant patient with inflammatory bowel disease.
    Steinlauf AF; Present DH
    Gastroenterol Clin North Am; 2004 Jun; 33(2):361-85, xi. PubMed ID: 15177544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lymphoma and other lymphoproliferative disorders in inflammatory bowel disease: a review.
    Subramaniam K; D'Rozario J; Pavli P
    J Gastroenterol Hepatol; 2013 Jan; 28(1):24-30. PubMed ID: 23094824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study.
    Moens A; van der Woude CJ; Julsgaard M; Humblet E; Sheridan J; Baumgart DC; Gilletta De Saint-Joseph C; Nancey S; Rahier JF; Bossuyt P; Cremer A; Dewit S; Eriksson C; Hoentjen F; Krause T; Louis E; Macken E; Milenkovic Z; Nijs J; Posen A; Van Hootegem A; Van Moerkercke W; Vermeire S; Bar-Gil Shitrit A; Ferrante M
    Aliment Pharmacol Ther; 2020 Jan; 51(1):129-138. PubMed ID: 31692017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tailored anti-TNF therapy during pregnancy in patients with IBD: maternal and fetal safety.
    de Lima A; Zelinkova Z; van der Ent C; Steegers EA; van der Woude CJ
    Gut; 2016 Aug; 65(8):1261-8. PubMed ID: 25966992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thiopurines prevent advanced colorectal neoplasia in patients with inflammatory bowel disease.
    van Schaik FD; van Oijen MG; Smeets HM; van der Heijden GJ; Siersema PD; Oldenburg B
    Gut; 2012 Feb; 61(2):235-40. PubMed ID: 21602529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-dose azathioprine or mercaptopurine in combination with allopurinol can bypass many adverse drug reactions in patients with inflammatory bowel disease.
    Ansari A; Patel N; Sanderson J; O'Donohue J; Duley JA; Florin TH
    Aliment Pharmacol Ther; 2010 Mar; 31(6):640-7. PubMed ID: 20015102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of tumor necrosis factor-α inhibitors on drug-induced pancreatitis in inflammatory bowel disease.
    Stobaugh DJ; Deepak P
    Ann Pharmacother; 2014 Oct; 48(10):1282-7. PubMed ID: 24982311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term follow-up of children exposed intrauterine to maternal thiopurine therapy during pregnancy in females with inflammatory bowel disease.
    de Meij TG; Jharap B; Kneepkens CM; van Bodegraven AA; de Boer NK;
    Aliment Pharmacol Ther; 2013 Jul; 38(1):38-43. PubMed ID: 23675854
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative study of pregnancy outcomes in women with inflammatory bowel disease treated with thiopurines and/or anti-TNF: a French nationwide study 2010-2018.
    Meyer A; Drouin J; Weill A; Carbonnel F; Dray-Spira R
    Aliment Pharmacol Ther; 2021 Aug; 54(3):302-311. PubMed ID: 34162011
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution of thiopurine use in pediatric inflammatory bowel disease in an academic center.
    Banerjee S; Bishop WP
    J Pediatr Gastroenterol Nutr; 2006 Sep; 43(3):324-30. PubMed ID: 16954954
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pregnancy outcome in women with inflammatory bowel disease treated with anti-tumor necrosis factor and/or thiopurine therapy: a multicenter study from Japan.
    Komoto S; Motoya S; Nishiwaki Y; Matsui T; Kunisaki R; Matsuoka K; Yoshimura N; Kagaya T; Naganuma M; Hida N; Watanabe M; Hibi T; Suzuki Y; Miura S; Hokari R;
    Intest Res; 2016 Apr; 14(2):139-45. PubMed ID: 27175114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.